FFCP PHASE1:Hg19::chr16:34980938..34980966,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=400533 | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_ncRNA | |||
|HGNC= | |||
|TSSclassifier=strong | |||
|UniProt= | |||
|association_with_transcript=15bp_to_NR_033985,uc002edz.1_5end | |||
|cluster_id=chr16:34980938..34980966,+ | |||
|coexpression_cluster_id=C464 | |||
|description=CAGE_peak_1_at_FLJ26245_5end | |||
|id=chr16:34980938..34980966,+ | |||
|ontology_enrichment_celltype=CL:0000319!2.71e-19!1;CL:0002149!3.34e-13!6;CL:0002255!3.34e-13!6;CL:0000159!2.49e-10!2;CL:0000054!2.99e-10!2;CL:0000137!2.99e-10!2;CL:0000092!2.99e-10!2;CL:1000415!3.58e-10!2 | |||
|ontology_enrichment_celltype_v019=CL:0002149;4.86e-23;6!CL:0002255;4.86e-23;6 | |||
|ontology_enrichment_celltype_v019_2=CL:0002149,4.86e-23,6;CL:0002255,4.86e-23,6 | |||
|ontology_enrichment_development_v019=UBERON:0005795;2.84e-14;10!UBERON:0007123;7.01e-08;5 | |||
|ontology_enrichment_disease=DOID:4468!2.73e-37!2;DOID:3030!2.71e-19!1;DOID:0060085!3.91e-19!1;DOID:3165!3.91e-19!1;DOID:0060121!3.91e-19!1;DOID:2438!3.91e-19!1;DOID:4418!3.91e-19!1;DOID:299!2.65e-18!25;DOID:3001!3.34e-13!6;DOID:120!3.44e-11!27;DOID:193!1.93e-10!29;DOID:305!1.96e-10!106;DOID:200!2.99e-10!2;DOID:4305!2.99e-10!2;DOID:0050687!1.18e-09!143;DOID:162!5.90e-07!235;DOID:14566!8.56e-07!239 | |||
|ontology_enrichment_disease_v019=DOID:4468;2.84e-66;2!DOID:3001;4.86e-23;6!DOID:299;1.09e-21;25!DOID:120;3.90e-20;27!DOID:193;8.53e-19;29 | |||
|ontology_enrichment_disease_v019_2=DOID:4468,2.84e-66,2;DOID:3001,4.86e-23,6;DOID:299,1.09e-21,25;DOID:120,3.90e-20,27;DOID:193,8.53e-19,29 | |||
|ontology_enrichment_uberon=UBERON:0001282!3.25e-19!1;UBERON:0009842!3.25e-19!1;UBERON:0003704!3.25e-19!1;UBERON:0001171!3.25e-19!1;UBERON:0001172!3.25e-19!1;UBERON:0002294!3.85e-11!7;UBERON:0001173!3.85e-11!7;UBERON:0004912!3.85e-11!7;UBERON:0002110!3.35e-07!3;UBERON:0006242!3.35e-07!3 | |||
|ontology_enrichment_uberon_v019=UBERON:0000995;8.23e-09;17!UBERON:0003975;2.25e-08;18!UBERON:0002046;7.01e-08;5!UBERON:0004175;2.60e-07;21 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002046,7.01e-08,5;UBERON:0004117,7.01e-08,5;UBERON:0007689,7.01e-08,5;UBERON:0007123,7.01e-08,5;UBERON:0003091,7.01e-08,5;UBERON:0000995,2.60e-07,21;UBERON:0005795,5.09e-07,22;UBERON:0003975,5.09e-07,22 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.227884111694002,0,0,0,0,0,0,0,0,0,0,0,0,0,0,173.22941097751,1.30586246527318,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.19871461170299,0,0,0.0801588202515337,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.171086837884329,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.491545817507439,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.3636865955379,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,84.9965496720236,31.5327849862553,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.03674705290208,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p1@FLJ26245 | |||
}} |
Latest revision as of 14:45, 16 September 2015
Short description: | p1@FLJ26245 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_1_at_FLJ26245_5end |
Coexpression cluster: | C464_clear_serous_pagetoid_squamous_chorionic_thyroid_renal |
Association with transcript: | 15bp_to_NR_033985, uc002edz.1_5end |
EntrezGene: | FLJ26245 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
epithelial cell of uterus | 4.86e-23 | 6 |
stromal cell of endometrium | 4.86e-23 | 6 |
Ontology term | p-value | n |
---|---|---|
thyroid gland | 7.01e-08 | 5 |
pharyngeal pouch | 7.01e-08 | 5 |
thyroid diverticulum | 7.01e-08 | 5 |
pharyngeal pouch 2 | 7.01e-08 | 5 |
thyroid primordium | 7.01e-08 | 5 |
uterus | 2.60e-07 | 21 |
embryonic uterus | 5.09e-07 | 22 |
internal female genitalia | 5.09e-07 | 22 |
Ontology term | p-value | n |
---|---|---|
clear cell adenocarcinoma | 2.84e-66 | 2 |
female reproductive endometrioid cancer | 4.86e-23 | 6 |
adenocarcinoma | 1.09e-21 | 25 |
female reproductive organ cancer | 3.90e-20 | 27 |
reproductive organ cancer | 8.53e-19 | 29 |